Uman Sense raises SEK 6.3 million with Prominent Investors
Cecilia Belfrage, CEO and co-founder of Uman Sense.
In an oversubscribed new share issue, the medtech company Uman Sense has raised SEK 6.3 million. Among the new co-owners are Gobia Enterprises, STOAF III SciTech and Queen Invest. Uman Sense has developed and CE-marked the medical device Stroke Alarm, a medical device which is now being tested in a clinical trial on patients at a high risk for stroke. The company is a member of SmiLe Incubator at Medicon Village in Lund.
Uman Sense’s medical device product Stroke Alarm is a wearable stroke detection system that consists of two bracelets with sensors and wireless communication with a smartphone. The purpose of Stroke Alarm is to provide early indication of suspected stroke so that the victim can access care in time for treatment. The product is intended for patients who are at high risk of stroke. Stroke Alarm addresses an important medical challenge and has already attracted great interest, including Region Skåne where a clinical trial has been initiated at several neurology clinics offering patients use of Stroke Alarm.
“One million brain cells are lost every minute during a stroke, so every minute saved from stroke onset to treatment increases the chance for the victim to survive and return to a good, productive life.
“There are great medical, human and socio-economic benefits to be made if stroke patients come into care as early as possible. One million brain cells are lost every minute during a stroke, so every minute saved from stroke onset to treatment increases the chance for the victim to survive and return to a good, productive life,” according to Johan Wasselius, associate professor and consultant interventional neuroradiologist at Skåne University Hospital and one of the inventors of Stroke Alarm.
Last spring Gobia Enterprises, one of the new co-owners, sold 75 percent of the Gothenburg-based family company Abigo Medical AB to the Essity Group. Abigo was valued at SEK 900 million prior to the transaction. Gobia Enterprises was originally formed to be an owner company of Abigo and will now also invest in and develop promising medtech and pharmaceutical start-up companies.
“Uman Sense is a very exciting medtech company operating in an area where there is a great clinical need and where there is a demand for new innovative products. We believe that they can add substantial value to healthcare globally, and we want to participate in creating positive solutions for these patients,” says Jan Erik Smith, Gobia Enterprises.
“It is great that we are able to bring in these strong and long-term partners. They will be able to contribute with their broad knowledge in building successful companies within life science,” says Cecilia Belfrage, CEO of Uman Sense.
Owners preceding this investment series include Christer Fåhraeus’ Fårö Capital among others.
Uman Sense is a member of SmiLe Incubator, a business incubator in Medicon Village in Lund, Sweden that helps innovation companies in the field of Life Science to convert their ideas into reality.
About SmiLe Venture Hub – Pioneering Life Science Innovations
SmiLe Incubator is a life science business incubator based in Medicon Village in Lund. SmiLe helps entrepreneurs to commercialize their ideas. There are currently 25 companies in SmiLe, which together with alumni companies, have attracted more than EUR 280 million in venture capital to date since 2014. SmiLe offers business coaching, a large network of contacts and a dynamic community, as well as well-equipped laboratories which is unique of its kind in Sweden. SmiLe is a non-profit organization and receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village. SmiLe´s sponsors are Agilent, Sparbanken Skåne, Awa, Høiberg, Prevas, Setterwalls, Zacco, Aqilion. SmiLe’s listed alumni companies have a market capitalization of almost EUR 750 million (Q4 2019).
www.smileincubator.life
Cecilia Belfrage, CEO and co-founder of Uman Sense.
Powered by Notified